Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%

Best and Worst Investments of 2012

By Ben Steverman - 2012-12-12T21:04:13Z

Photograph by Mark Harmel/Getty Images

Company Symbol % Change
2 of 18

Best U.S. Large-Cap Stock

Regeneron Pharmaceuticals

+219%

Among the good news for Regeneron (REGN) shareholders were strong sales for a treatment for eye diseases. Total revenue jumped fourfold last quarter. The Tarrytown, N.Y.-based company also won approval for a chemotherapy drug and is developing drugs to treat rheumatoid arthritis and high cholesterol.

Universe and criteria: 358 stocks on U.S. exchanges with market capitalizations of more than $10 billion.

Advertisement